Pyxis Oncology, Inc. (PYXS)
1.67
+0.13
(+8.44%)
USD |
NASDAQ |
Mar 16, 16:00
1.665
0.00 (0.00%)
After-Hours: 20:00
Pyxis Oncology Shareholders Equity (Quarterly) : 68.78M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 52.61B |
| Nephros, Inc. | 10.20M |
| Spero Therapeutics, Inc. | 26.49M |
| Processa Pharmaceuticals, Inc. | 5.834M |
| Alpha Teknova, Inc. | 68.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 105.60M |
| Total Liabilities (Quarterly) | 36.82M |
| Debt to Equity Ratio | 0.2773 |
| Current Ratio | 4.286 |
| Net Debt Paydown Yield | 0.26% |